Jacques Y Roberge

This inventor holds 28 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bristol-Myers Squibb Compnay, Theracos, Inc., Theracos Sub, LLC. Active years: 1997-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques Y Roberge. Retrieved from https://idiyas.com/inventor/jacques-y-roberge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 7)

% Patents Active = 92.9

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 8.0

ph-index = 8

Forward Citations = 197(Granted Patents)

Location History:

Shanghai, CN (2010 - 2015)
Princeton, NJ (US) (1997 - 2021)

Company Filing History:

14 out of 3,745

Bristol-Myers Squibb Compnay

Sloan-Kettering Institute for Cancer Research

patents

Years Active: 1997-2021

Loading Chart...

Areas of Expertise:

SGLT2 Inhibitors

Benzylbenzene Derivatives

CETP Inhibitors

Calcium Sensing Receptor Modulators

Heterocyclic Compounds

Fused Succinimide Compounds

Hydroxy-benzylbenzene Derivatives

Protein Tyrosine Kinase Inhibitors

Purine Inhibitors

Asparagine-linked Glycopeptides

Deuterated Benzylbenzene Derivatives

Substituted Piperidines

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10981942 - Crystalline form of benzylbenzene SGLT2 inhibitor (2021-04-20),

2. 10533032 - Crystalline form of benzylbenzene SGLT2 inhibitor (2020-01-14),

3. 10093616 - Preparation of hydroxy-benzylbenzene derivatives (2018-10-09),

4. 9834573 - Crystalline form of benzylbenzene SGLT2 inhibitor (2017-12-05),

5. 9725478 - Process for the preparation of benzylbenzene SGLT2 inhibitors (2017-08-08),

6. 9464043 - Preparation of hydroxy-benzylbenzene derivatives (2016-10-11),

7. 9193751 - Process for the preparation of benzylbenzene SGLT2 inhibitors (2015-11-24),

8. 9061060 - Deuterated benzylbenzene derivatives and methods of use (2015-06-23),

9. 8987323 - Crystalline form of benzylbenzene SGLT2 inhibitor (2015-03-24),

10. 8802637 - Benzylbenzene derivatives and methods of use (2014-08-12),

11. 8642576 - Heterocyclic CETP inhibitors (2014-02-04),

12. 8575321 - Benzylbenzene derivatives and methods of use (2013-11-05),

13. 8304403 - Heterocyclic CETP inhibitors (2012-11-06),

14. 8106021 - Benzylbenzene derivatives and methods of use (2012-01-31),

15. 8053450 - [object Object] (2011-11-08),

Title: The Innovative Journey of Jacques Y Roberge

Introduction: Jacques Y Roberge is a visionary inventor based in Princeton, NJ, whose groundbreaking work has left a lasting impact on the world of technology and innovation.

Latest Patents: Jacques Y Roberge holds several patents in the field of renewable energy technologies, including a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over 20 years of experience in the industry, Jacques Y Roberge has worked for leading tech companies, contributing to the development of cutting-edge solutions in sustainable energy and environmental conservation.

Collaborations: Throughout his career, Jacques Y Roberge has collaborated with top researchers and engineers from renowned universities and research institutions, fostering a culture of innovation and excellence in his projects.

Conclusion: Jacques Y Roberge's dedication to pushing the boundaries of technology and his passion for creating a more sustainable future make him a true pioneer in the field of innovation.

Profile summary based on public USPTO records.